Zoledronic acid inhibits cancer treatment-induced bone loss in premenopausal patients with breast cancer who are receiving adjuvant endocrine treatment

被引：0
|
作者：
不详
机构：
来源：
BREAST | 2005年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [31] Breast Cancer and Osteoporosis - Management of Cancer Treatment-Induced Bone Loss in Postmenopausal Women with Breast Cancer
    Kalder, Matthias
    Hadji, Peyman
    BREAST CARE, 2014, 9 (05) : 312 - 317
  • [32] Influence of Zoledronic Acid on BMD in Premenopausal Women with Breast Cancer and Neoadjuvant or Adjuvant Chemotherapy and/or Endocrine Treatment - The ProBone Studies.
    Hadji, P.
    Kauka, A.
    Bauer, T.
    Kalder, M.
    Albert, U.
    Birkholz, K.
    Baier, M.
    Muth, M.
    Ziller, M.
    CANCER RESEARCH, 2011, 71
  • [33] Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment
    Hadji, P.
    Kauka, A.
    Kalder, M.
    Bauer, T.
    Albert, U.
    Muth, M.
    Ziller, M.
    EJC SUPPLEMENTS, 2010, 8 (03): : 62 - 62
  • [34] Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment
    Ziller, M.
    Hadji, P.
    Kauka, K.
    Bauer, T.
    Albert, U. S.
    Muth, M.
    Kalder, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 277 - 277
  • [35] Recent Advances in Management of Cancer Treatment-induced Bone Loss (CTIBL) in Patients with Breast or Prostate Cancer
    Kim, Soo Hyun
    Hong, Seongbin
    Song, Youngkyu
    Song, Hosook
    ASIAN ONCOLOGY NURSING, 2013, 13 (03) : 103 - 112
  • [36] A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss
    Santini, D.
    Vincenzi, B.
    Caraglia, M.
    Tonini, G.
    ANNALS OF ONCOLOGY, 2007, 18 (01) : 201 - U5
  • [37] Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
    Gelber, Richard D.
    Aebi, Stefan
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22): : 2367 - 2367
  • [38] Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
    Gnant, Michael
    Mlineritsch, Brigitte
    Schippinger, Walter
    Luschin-Ebengreuth, Gero
    Poestlberger, Sabine
    Menzel, Christian
    Jakesz, Raimund
    Seifert, Michael
    Hubalek, Michael
    Bjelic-Radisic, Vesna
    Samonigg, Hellmut
    Tausch, Christoph
    Eidtmann, Holger
    Steger, Guenther
    Kwasny, Werner
    Dubsky, Peter
    Fridrik, Michael
    Fitzal, Florian
    Stierer, Michael
    Rucklinger, Ernst
    Greil, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (07): : 679 - 691
  • [39] Zoledronic acid (ZA) for prevention of cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (let): Preliminary results of the Z-FAST trial
    Brufsky, A
    Harker, G
    Beck, T
    Carroll, R
    Tan-Chiu, E
    Seidler, C
    Lacema, L
    Thomas, E
    Perez, E
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S233 - S233
  • [40] Emerging recommendations for the prevention of cancer treatment-induced bone loss in women with breast cancer
    Costa, L.
    Guise, T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 304 - 304
12345